MedTrace Logo

Efficacy of Fish Oil in Lupus Patients

NCT00828178 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2016-11-18

Study results available
· View outcomes & findings →

Summary

The investigators hypothesize that low-dose dietary supplementation with omega-3 fish oil will improve disease activity and endothelial function in Systemic Lupus Erythematosus (SLE) patients.

Conditions

Interventions

DRUG

Omega-3

Omega-3-acid ethyl esters (Lovaza) 3 gram once a day for 12 weeks

DEVICE

flow-mediated dilation of the brachial artery

flow-mediated dilation of the brachial artery measurement at baseline and after 12 weeks

OTHER

corn starch

3 capsules qd for 12weeks

Sponsors & Collaborators

  • Michelle Petri M.D.,MPH

    lead OTHER

Principal Investigators

  • Michelle A Petri, MD, MPH · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00828178 on ClinicalTrials.gov